Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Blood-Based Biomarkers for Response to Immune Checkpoint Inhibitors

NCT06630429 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT06630429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06630429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Blood-Based Biomarkers for Response to Immune Checkpoint Inhibitors
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
September 2, 2020
Completion date
July 31, 2027
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer, renal cell carcinoma (rcc)